1,785 results on '"Deanfield, John"'
Search Results
52. The Assessment of Endothelial Function
53. Advocacy at the Eighth World Congress of Pediatric Cardiology and Cardiac Surgery
54. 36 An analysis of the virtual cardio-oncology research initiative (VICORI) resource: bleeding risk among acute coronary syndrome patients with cancer
55. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
56. Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?
57. Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes?
58. Abstract 16467: A Novel CT-derived Radiotranscriptomic Signature of Perivascular Adipose Tissue Stratifies COVID-19 Vascular Cytokine Burst and Predicts in Hospital Outcomes
59. Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort
60. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data
61. Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: SOUL , a randomized trial, design and baseline characteristics
62. Medical history predicts phenome-wide disease onset
63. Acute heart failure presentation, management and outcomes in cancer patients: a national longitudinal study
64. Abstract P6-08-04: Geographical variation of social deprivation, cardiovascular and other comorbidities in 226,516 patients with early breast cancer in England: results from a National Registry Dataset Analysis
65. Social Determinants of Health Are Associated with Modifiable Risk Factors for Cardiovascular Disease and Vascular Function in Pediatric Type 1 Diabetes
66. Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes
67. Arterial disease in the young
68. Nomenclature
69. Clinical presentations and initial investigations
70. Complete transposition of the great arteries
71. Total anomalous pulmonary venous connection
72. Introduction
73. Epidemiology and incidence
74. Atherosclerosis
75. Associations between arterial stiffening and brain structure, perfusion, and cognition in the Whitehall II Imaging Sub-study: A retrospective cohort study
76. Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials
77. GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes
78. Reproducibility and biological variability of HDL's vascular functional assays
79. Structural and functional changes in HDL with low grade and chronic inflammation
80. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
81. Genome-wide association study of longitudinal urinary albumin excretion in patients with type 1 diabetes
82. Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom : population based cohort study using nationwide clinical registries
83. P97 Age Modifies the Relationship Between Arterial Stiffness, Adiposity and Blood Pressure from Adolescence to Adulthood in Men and Women
84. Treatment With Once-weekly Semaglutide 2.4 mg Improves Cardiometabolic Risk Factors in Adults With Overweight or Obesity and Type 2 Diabetes: STEP 2 Post Hoc Analysis
85. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
86. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
87. Is the ESC blowing its own trumpet or should it have a deserved fanfare? The impact and power of registry data
88. In Memoriam: Marc R. de Leval (1941-2022)
89. In Memoriam: Professor Marc R. de Leval (April 16, 1941–June 26, 2022) - a tribute
90. Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60–64 years in the 1946 British birth cohort study: an epidemiological study
91. Genetic Variants at Chromosome 9p21 and Risk of First Versus Subsequent Coronary Heart Disease Events: A Systematic Review and Meta-Analysis
92. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
93. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK
94. 209 - Semaglutide and cardiovascular outcomes in patients with overweight or obesity who do not have diabetes
95. Childhood Fat and Lean Mass: Differing Relations to Vascular Structure and Function at Age 8 to 9 Years
96. Association between resting heart rate across the life course and all-cause mortality: longitudinal findings from the Medical Research Council (MRC) National Survey of Health and Development (NSHD)
97. ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes
98. Clustering of cardio‐metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria
99. Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.
100. Patterns of adiposity, vascular phenotypes and cognitive function in the 1946 British Birth Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.